Gara Jalqabaatti › Kansarii Prostate › Oklahoma › Oklahoma City
Qorannoo klinikaalii Kansarii Prostate Oklahoma City, OK keessatti
Qorannoo 21 Kansarii Prostate f Oklahoma City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Oklahoma, Oklahoma City
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Namoota walitti qabaa jiraSadarkaa 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Mercy Hospital Oklahoma City, Oklahoma City
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Namoota walitti qabaa jiraSadarkaa 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Namoota walitti qabaa jiraSadarkaa 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Oklahoma Proton Center, Oklahoma City
Protoacoustic Imaging For 3D Mapping
Namoota walitti qabaa jiraQorannoo ilaalaa
- OU Health Stephenson Cancer Center, Oklahoma City
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Hightower Clinical, Oklahoma City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Oklahoma Health Sciences Center, Oklahoma City
The Vanguard Study: Testing a New Way to Screen for Cancer
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- University of Oklahoma Health Sciences Center, Oklahoma City
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
Namoota walitti qabaa jiraQorannoo ilaalaa
- OU Health Stephenson Cancer Center, Oklahoma City
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Namoota walitti qabaa jiraSadarkaa 3
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
A Study of DM002 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Namoota walitti qabaa jiraSadarkaa 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
Namoota walitti qabaa jira
- University of Oklahoma HSC, Oklahoma City
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Namoota walitti qabaa jiraSadarkaa 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Namoota walitti qabaa jiraSadarkaa 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- OU Health Stephenson Cancer Center, Oklahoma City
Connect2Care: Prostate Cancer Education and Screenings for African American Men
Namoota walitti qabaa jira
- TSET Health Promotion Research Center, Oklahoma City
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Oklahoma Health Sciences Center, Oklahoma City
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Exelixis Clinical Site #13, Oklahoma City
Qorannoo Kansarii Prostate magaalota biroo keessatti
- New York City, NYQorannoo 103
- Houston, TXQorannoo 76
- Los Angeles, CAQorannoo 61
- Boston, MAQorannoo 59
- St. Louis, MOQorannoo 46
- Chicago, ILQorannoo 45
- San Francisco, CAQorannoo 45
- Philadelphia, PAQorannoo 44
- Baltimore, MDQorannoo 43
- Nashville, TNQorannoo 42
- Seattle, WAQorannoo 42
- Washington, DCQorannoo 38
Qorannoo biroo Oklahoma City keessatti
- Kansara Qara'a Non-Small CellQorannoo 28
- Kansarii OvariiQorannoo 28
- Kansa EndometiriyaaliiQorannoo 25
- Kansarii ColorectalQorannoo 22
- Dhibee QaraQorannoo 19
- Saree OljooQorannoo 17
- Kansara MetastatikiiQorannoo 15
- Saree (Gosoota Hunda)Qorannoo 14
- Leukemia Myeloidii HamaaQorannoo 14
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 13
- Kansarii PancreasQorannoo 11
- Dukkana BladderQorannoo 11
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.